1. Kubo A, Nakamura K, Sammiya T, Shimizu S, Hashimoto S, Iwanaga S, et al. Phase I clinical study of99mTc-MIBI.KAKU IGAKU (Jpn J Nucl Med) 28: 1133–1142, 1991.
2. Wackers FJT, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.J Nucl Med 30: 301–310, 1989.
3. Sands H, Delano ML, Gallaghe BM. Uptake of hexakis (tbutylisonitrile) technetium(I) and hexakis-(isopropylisonitrile) technetium(I) by neonatal rat myocytes and human erythrocytes.J Nucl Med 27: 404–408, 1986.
4. Chiu ML, Herman ZW, Kronauge JF, Piwnica-Worms D. Comparative effects of neutral dipolar compounds and lipophilic anions on Technetium-99m-hexakis(2-methoxyisobutyl isonitrile) accumulation in cultured chick ventricular myocytes.Invest Radiol 27: 1052–1058, 1992.
5. Maublant JC, Moins N, Gachon P, Renoux M, Zhang Z, Veyre A. Uptake of Technetium-99-teboroxime in cultured myocardial cells: Comparison with Thallium-201 and Technetium-99m-sestamibi.J Nucl Med 34: 255–259, 1993.